HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.

AbstractOBJECTIVE:
To evaluate if new imiquimod formulations using a shorter treatment duration are safe and efficacious to treat anogenital warts.
METHODS:
In two studies 534 women ≥12 years of age (mean 33.4) with 2-30 warts (mean 7.9) and total wart area ≥10 mm(2) (mean 166.3) were randomized (1:2:2) to placebo (106), imiquimod 2.5% (212) or 3.75% (216) creams applied once daily until complete clearance or a maximum of 8 weeks.
RESULTS:
For placebo, imiquimod 2.5% and 3.75%, respectively, complete clearance of all warts was achieved in 14.2%, 28.3%, and 36.6% of women (intent-to-treat, P = 0.008 imiquimod 2.5%, and P < 0.001 3.75% versus placebo). Mean changes in wart counts were -10.7%, -50.9%, and -63.5% (per-protocol, P < 0.001 each active versus placebo) and safety-related discontinuation rates 0.9%, 1.4%, and 2.3%.
CONCLUSIONS:
Imiquimod 3.75% applied daily for up to 8 weeks was well tolerated and superior to placebo in treating women with external anogenital warts.
AuthorsDavid A Baker, Daron G Ferris, Mark G Martens, Kenneth H Fife, Stephen K Tyring, Libby Edwards, Anita Nelson, Kevin Ault, Kenneth F Trofatter, Tiepu Liu, Sharon Levy, Jason Wu
JournalInfectious diseases in obstetrics and gynecology (Infect Dis Obstet Gynecol) Vol. 2011 Pg. 806105 ( 2011) ISSN: 1098-0997 [Electronic] Egypt
PMID21876641 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminoquinolines
  • Antiviral Agents
  • Placebos
  • Imiquimod
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aminoquinolines (administration & dosage, adverse effects)
  • Antiviral Agents (administration & dosage, adverse effects)
  • Condylomata Acuminata (drug therapy)
  • Data Interpretation, Statistical
  • Female
  • Genital Diseases, Female (drug therapy, virology)
  • Humans
  • Imiquimod
  • Middle Aged
  • Placebos
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: